$30.30
+0.280 (+0.93%)
At Close: Jun 03, 2026
How to Trade Penny Stocks in April 2022 and 3 to Watch
03:30pm, Sunday, 27'th Mar 2022 PennyStocks
Here's what you need to know about trading penny stocks in April
The post How to Trade Penny Stocks in April 2022 and 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | Pe
How to Trade Penny Stocks in April 2022 and 3 to Watch
11:30am, Sunday, 27'th Mar 2022
Here's what you need to know about trading penny stocks in April The post How to Trade Penny Stocks in April 2022 and 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | Pe
Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2022
02:19pm, Wednesday, 23'rd Mar 2022 Benzinga
Upgrades
For E2open Parent Holdings Inc (NYSE:ETWO), Colliers Securities upgraded the previous rating of Neutral to Buy. At the moment, the stock has a 52-week-high of $14.58 and a 52-week-low of $7.6
Rigel Pharmaceuticals: Why The Stock Is On A Run
05:35pm, Monday, 21'st Mar 2022
RIGL announced Q4'21 earnings in early March leading the stock to rally over 20%.
Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) Stock Forecast: $11.00 Per Share In 2022 With Positive Signs
04:30pm, Wednesday, 09'th Mar 2022 Marketing Sentinel
In the last trading session, 3.14 million shares of the Rigel Pharmaceuticals Inc. (NASDAQ:RIGL) were traded, and its beta was 1.37. Most recently the company’s share price was $3.13, and it changed around $0.04 or 1.29% from the last close, which brings the market valuation of the company to $539.11M. RIGL currently trades at a … Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) Stock Forecast: $11.00 Per Share In 2022 With Positive Signs Read More »
68 Biggest Movers From Yesterday
08:53am, Thursday, 03'rd Mar 2022 Benzinga
Gainers ECMOHO Limited (NASDAQ: MOHO ) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP ) shares jumped 39.2% to close at $2.06 after dipping 37% on Tuesday. Nordstrom, Inc. (NYSE: JWN ) shares jumped 37.8% to settle at $26.93 after the company reported better-than-expected Q4 EPS and sales results. The company also issued FY22 guidance. Regulus Therapeutics Inc. (NASDAQ: RGLS ) gained 35.6% to close at $0.3050. Indonesia Energy Corporation Limited (NASDAQ: INDO ) surged 34.5% to close at $14.50. Trevi Therapeutics, Inc. (NASDAQ: TRVI ) gained 32% to settle at $1.15. Arlo Technologies, Inc. (NYSE: ARLO ) rose 28.9% to close at $11.19 after the company reported better-than-expected Q4 results. The company also issued Q1 sales guidance above analyst estimates. Rocky Brands, Inc. (NASDAQ: RCKY ) climbed 26.6% to close at $47.47 following better-than-expected Q4 results. China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC ) gained 26.1% to close at $0.2181.
Rigel Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call Presentation
05:36am, Wednesday, 02'nd Mar 2022 Seeking AlphaRigel Pharmaceuticals, Inc. (RIGL) CEO Raul Rodriguez on Q4 2021 Results - Earnings Call Transcript
05:31am, Wednesday, 02'nd Mar 2022 Seeking AlphaRigel Pharmaceuticals, Inc. (RIGL) CEO Raul Rodriguez on Q4 2021 Results - Earnings Call Transcript
12:31am, Wednesday, 02'nd Mar 2022
Rigel Pharmaceuticals, Inc. (RIGL) CEO Raul Rodriguez on Q4 2021 Results - Earnings Call Transcript
Rigel Pharmaceuticals (RIGL) Reports Q4 Loss, Misses Revenue Estimates
10:45pm, Tuesday, 01'st Mar 2022 Zacks Investment Research
Rigel (RIGL) delivered earnings and revenue surprises of 0% and 3.71%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Rigel Pharmaceuticals GAAP EPS of -$0.13 in-line, revenue of $20.41M misses by $0.79M
09:31pm, Tuesday, 01'st Mar 2022 Seeking Alpha
Rigel Pharmaceuticals press release (RIGL): Q4 GAAP EPS of -$0.13 in-line.Revenue of $20.41M (+10.6% Y/Y) misses by $0.79M.
Rigel Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
09:01pm, Tuesday, 01'st Mar 2022 PR Newswire
SOUTH SAN FRANCISCO, Calif., March 1, 2022 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the fourth quarter and full year ended December 31, 2021, including sales of TAVALISSE® (fostamatinib disodium hexahydrate) tablets for the treatment…
Rigel Pharmaceuticals (RIGL) Reports Q4 Loss, Misses Revenue Estimates
07:10pm, Tuesday, 01'st Mar 2022
Rigel (RIGL) delivered earnings and revenue surprises of 0% and 3.71%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Rigel Pharmaceuticals Q4 2021 Earnings Preview (NASDAQ:RIGL)
10:35pm, Monday, 28'th Feb 2022 Seeking Alpha
Rigel Pharmaceuticals (NASDAQ:RIGL) is scheduled to announce Q4 earnings results on Tuesday, March 1st, after market close.The consensus EPS Estimate is -$0.12 (-9.1% Y/Y) and the…
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End 2021 Financial Results and Business Update
01:30pm, Tuesday, 22'nd Feb 2022 PR Newswire
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2022 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its fourth quarter and year end 2021 financial results after market close on Tuesday, March 1, 2022. Rigel senior management will follow the
Sign In
Buy RIGL